Kwality Pharmaceuticals receives GMP approval from SFDA for its two manufacturing units in Amritsar

Kwality Pharmaceuticals Limited has achieved a significant milestone by securing GMP (Good Manufacturing Practice) approval for its two audited manufacturing units in Amritsar.

This prestigious certification, granted by the Saudi Food and Drug Authority (SFDA), positions Kwality Pharmaceuticals for expanded global reach, particularly within the Middle East and beyond.

Advertisement

The approval covers two specialized production lines:

  • Unit-1: Focused on generic injectable sterile products, including lyophilized injectables, small volume liquids, dry powder for injection, and terminally sterilized small volume liquids.
  • Unit-2: Specializes in beta-lactam sterile products, particularly penicillins and dry powder injectables.

As a member of PIC/S (Pharmaceutical Inspection Cooperation Scheme), the SFDA’s recognition ensures that Kwality Pharma’s products meet rigorous international standards. This certification provides a gateway to enter key markets such as Saudi Arabia, UAE, Jordan, Bahrain, Kuwait, Oman, and Qatar. Additionally, the approval offers access to over 50+ PIC/S member countries through mutual recognition agreements.